HomeREGULATORY
REGULATORY

MHLW Advisory Panel to Review Budesonide Rectal Foam on Sept. 1
(Aug.21.2017)

A key advisory committee of the Ministry of Health, Labor and Welfare (MHLW) will discuss on September 1 whether to recommend approval for a rectal foam containing budesonide, filed by Eisai’s GI subsidiary EA Pharma, for the treatment of ulcerative colitis ...
(LOG IN FOR FULL STORY)

News Calendar